ArticleCancer chemotherapy and pharmacology2026

Outcomes of locally produced donor-derived anti-CD19 chimeric antigen receptor T-cells in relapsed or refractory B-cell acute lymphoblastic leukemia patients.

Supavich Tannumsaeng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.